Adults aged 18+ with a BMI of 30 or above, or a BMI of 27+ with a weight-related condition such as high blood pressure, high cholesterol or type 2 diabetes
Glucagon is the hormone your body uses to mobilize stored energy
A structured rotation approach is strongly recommended: Rotate with every dose do not use the same spot twice in succession Divide each injection area into a grid of smaller zones , moving systematically from one zone to the next with each injection Allow at least 12 cm between injection points within the same region Alternate between body areas in line with your trial or device instructions for example, using the abdomen for one dose and the thighs for the next Keep a simple log or use a rotation chart to track where the last injection was given Examine your injection sites regularly
Under normal physiological conditions, GLP-1 enhances glucose-dependent insulin secretion from pancreatic beta cells, suppresses glucagon release, slows gastric emptying, and promotes satiety
Updated February 2026 GLP-1 Drug Comparison Tool: Compare Weight Loss Drugs Side by Side Interactive comparison tool for GLP-1 weight loss drugs
Clinical studies have demonstrated substantial effects on body weight and metabolic health, making it one of the most discussed peptides currently available
